438 related articles for article (PubMed ID: 8386728)
1. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
2. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma.
Springfield D
J Bone Joint Surg Am; 1993 Dec; 75(12):1880-1. PubMed ID: 8258559
[No Abstract] [Full Text] [Related]
3. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
5. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases.
Kobayashi Y; Ozaki T; Takeda Y; Kawai A; Inoue H
Acta Orthop Scand; 1998 Dec; 69(6):611-6. PubMed ID: 9930108
[TBL] [Abstract][Full Text] [Related]
7. Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
Choong PF; Nizam I; Ngan SY; Schlict S; Powell G; Slavin J; Smith P; Toner G; Hicks R
Eur J Surg Oncol; 2003 Dec; 29(10):908-15. PubMed ID: 14624787
[TBL] [Abstract][Full Text] [Related]
8. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.
Lin J; Leung WT; Ho SK; Ho KC; Kumta SM; Metreweli C; Johnson PJ
Eur J Nucl Med; 1995 Jun; 22(6):553-5. PubMed ID: 7556302
[TBL] [Abstract][Full Text] [Related]
11. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
[No Abstract] [Full Text] [Related]
12. [Prognostic factors of bone and soft tissue sarcomas].
Furuse K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2050-5. PubMed ID: 3293534
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
[TBL] [Abstract][Full Text] [Related]
14. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy.
Kunisada T; Ozaki T; Kawai A; Sugihara S; Taguchi K; Inoue H
Cancer; 1999 Sep; 86(6):949-56. PubMed ID: 10491520
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
16. [Pre- and postoperative chemotherapy in bone and soft tissue tumors].
Höffken K
Langenbecks Arch Chir; 1987; 372():311-4. PubMed ID: 3481009
[TBL] [Abstract][Full Text] [Related]
17. [Angiotensin II-induced hypertension chemotherapy of bone and soft-tissue sarcomas].
Tsuchiya H; Tomita K; Sugihara M; Shimizu H; Yasutake H; Morishita H; Morikawa S; Ohno M; Bunko H; Seto M
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1776-81. PubMed ID: 2543322
[TBL] [Abstract][Full Text] [Related]
18. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
[TBL] [Abstract][Full Text] [Related]
19. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
[TBL] [Abstract][Full Text] [Related]
20. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]